A prospective cohort study evaluating the role of quantifying sonographic inflammatory changes in GCA

Area of Science:

• Rheumatology
• Medical Imaging
• Clinical Diagnostics

Background:

• Vascular ultrasound (VUS) is established for diagnosing Giant Cell Arteritis (GCA).
• The utility of VUS in monitoring GCA disease progression and predicting patient outcomes requires further definition.

Purpose of the Study:

• To evaluate the role of sonographic vasculitis quantification in GCA diagnosis and management.
• To assess longitudinal trends and normalization of VUS parameters.
• To determine patient factors predicting VUS outcomes and adverse events.

Main Methods:

• Prospective cohort study of GCA patients.
• Comparison of intima-media thickness (IMT), Halo Count (HC), Halo Score (HS), and OMERACT GCA US Score (OGUS) over 12 months.
• Correlation and AUC analyses to identify predictors of VUS outcomes and adverse events.

Main Results:

• Significant declines in mean HC, HS, IMT, and OGUS observed over 12 months.
• Normalization of HC, HS, and OGUS achieved by 6 months in a substantial proportion of patients.
• VUS scores, especially OGUS, demonstrated superior predictive value for adverse events compared to clinical and laboratory parameters.

Conclusions:

• VUS quantification scores, particularly OGUS, are validated biomarkers for GCA in a prospective cohort.
• These sonographic measures outperform clinical variables in predicting adverse events.
• VUS quantification scores hold potential as key outcome variables in GCA clinical trials.